Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism
about
Porcine PD-L1: cloning, characterization, and implications during xenotransplantationThe PD-1 pathway in tolerance and autoimmunityMacrophages: contributors to allograft dysfunction, repair, or innocent bystanders?Effector mechanisms of rejectionThe role of the PD-1 pathway in autoimmunity and peripheral toleranceRecruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptorEvolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell TransplantationThe humanized NOD/SCID mouse as a preclinical model to study the fate of encapsulated human isletsHerpes keratitis.B7-H3 promotes acute and chronic allograft rejection.Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.Streptozotocin-associated lymphopenia in cynomolgus monkeys.PD-L1-driven tolerance protects neurogenin3-induced islet neogenesis to reverse established type 1 diabetes in NOD mice.Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody.α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejectionThe PDL1-PD1 axis converts human TH1 cells into regulatory T cells.Mechanisms of indirect acute lung injury: a novel role for the coinhibitory receptor, programmed death-1.Array-based methods for diagnosis and prevention of transplant rejection.Coinhibitory T-cell signaling in islet allograft rejection and tolerance.Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction.MicroRNA-33 suppresses CCL2 expression in chondrocytes.Biomarkers for type 1 diabetes.Challenges and emerging technologies in the immunoisolation of cells and tissues.Novel biomarkers in type 1 diabetes.Antiproinflammatory effects of iodixanol (OptiPrep)-based density gradient purification on human islet preparations.Chemokines and transplant vasculopathy.The complex role of B7 molecules in tumor immunologyUsing histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance.Innate immunity and heat shock response in islet transplantation.Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases.NOX4 Regulates CCR2 and CCL2 mRNA Stability in Alcoholic Liver Disease.Anti-inflammatory strategies to enhance islet engraftment and survival.Therapeutic potential of laminin-biodritin microcapsules for type 1 diabetes mellitus.CCR2 regulates monocyte recruitment as well as CD4 T1 allorecognition after lung transplantation.Anti-proinflammatory effects of sirolimus on human islet preparations.Human islets express a marked proinflammatory molecular signature prior to transplantation.High levels of donor CCL2/MCP-1 predict graft-related complications and poor graft survival after kidney-pancreas transplantation.Role of CCL2/MCP-1 in islet transplantation.Effect of short-term culture on functional and stress-related parameters in isolated human islets.
P2860
Q24305180-E8DCAAAA-A3B9-452C-BE3F-D48621680746Q24633549-DF7D204E-8A2A-4602-A699-CEC79BDE6AEBQ26998846-BB5092B3-7E25-41BE-9112-811251B35649Q27027082-C970633C-DB31-4A2F-981A-13AF996CF3F8Q28304161-0FEB3466-FD74-4CD2-921D-7EE81EF1B3D8Q28595009-B217835C-86B0-4229-8954-7976E87384E6Q30430239-0B39E379-0A1B-427C-A540-AC3D990B61ACQ34072336-FE496AD0-7566-436D-837C-B4BF1A31B22DQ34297293-89D62CC8-2A3D-402D-ACD7-E5D758AED4F9Q34389662-4B3BD995-3083-40B1-9249-102BE51377BEQ34583370-98C12C3C-8613-456E-813C-F37CE0A73E6FQ34936411-091F71B3-BBBE-4E12-9795-F7F8E5BC2159Q35004384-A03E771D-C08E-468B-97AF-77C2993E5678Q35118386-411066C3-2F08-4642-B212-64F2226254CDQ35286904-310C23C9-9D51-411A-977B-D9D0A78BDD3DQ35607698-F17A8099-E7A3-47BE-9208-CD4862E6A89FQ35626868-5F94C736-6546-4BA9-9E7D-6DA0CBBE9392Q36411672-9D5CBE7A-86A9-4AFB-BE24-957FB093A3F8Q36485931-048BE6FD-92F2-4450-8C94-DDB4B0B38C4FQ36560836-D8042D52-4400-4F60-806A-1A5707BA248DQ36876612-FF200DC6-CFD9-4DF0-9E1F-AB0872ED16A9Q37000150-B3D5B4F7-5526-4A83-95DB-FF47DA066343Q37006047-8C5692B8-4EAD-45BC-B01B-F2EF6A4A88A0Q37088197-04410386-CE88-4172-B95F-D244C1BE563EQ37183811-15F38B7E-408F-4DFF-BD11-E77ADBD4B65CQ37256207-7CC53EF9-A3FB-41FC-9349-31BBEF3F6A0EQ37304913-86467FEA-06CD-4BC5-9492-FC3543F8BD73Q37378417-14F11787-F8FB-4836-95C0-298EFA0428E5Q37419472-9B4358E9-8295-4693-8E35-AC0A7346CF31Q37536067-D01063A5-356C-4E15-88EE-C14EBB8A9EC8Q37723178-794598FE-8DBA-4D92-A80A-D70B08B49C9CQ37739608-EE017F68-09BF-4EAD-B68D-25D7D0D598B4Q38126385-EAE44884-F1C9-47C2-9EE5-E2B28EBF1095Q39060694-A224621D-295A-4FB5-B693-ECC5634CE4A9Q42559685-3E11D568-A86D-4A09-8857-25DB0AE5E980Q43169964-216A88EF-A4ED-40C2-9B89-CDF9BF29AF52Q44081099-31AD19BC-814A-4F18-8A62-D2CFCB7C9479Q44506921-EC41BEB0-6758-43ED-8FE1-E64C90C97839Q45151585-ADBD14ED-B4B3-4B21-BFE0-B793D9EE5E0DQ46293013-D083CC1F-5D84-4DAD-B955-E81FE64CBAC4
P2860
Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism
description
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Dezember 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/12/15)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/12/15)
@nl
наукова стаття, опублікована в грудні 2003
@uk
مقالة علمية (نشرت في 15-12-2003)
@ar
name
Blocking the monocyte chemoatt ...... 1 ligand-1-dependent mechanism
@ast
Blocking the monocyte chemoatt ...... 1 ligand-1-dependent mechanism
@en
Blocking the monocyte chemoatt ...... 1 ligand-1-dependent mechanism
@nl
type
label
Blocking the monocyte chemoatt ...... 1 ligand-1-dependent mechanism
@ast
Blocking the monocyte chemoatt ...... 1 ligand-1-dependent mechanism
@en
Blocking the monocyte chemoatt ...... 1 ligand-1-dependent mechanism
@nl
prefLabel
Blocking the monocyte chemoatt ...... 1 ligand-1-dependent mechanism
@ast
Blocking the monocyte chemoatt ...... 1 ligand-1-dependent mechanism
@en
Blocking the monocyte chemoatt ...... 1 ligand-1-dependent mechanism
@nl
P2093
P3181
P1476
Blocking the monocyte chemoatt ...... 1 ligand-1-dependent mechanism
@en
P2093
Andrew D. Wells
Barrett J. Rollins
Lieping Chen
Liqing Wang
Martin E. Dorf
Rongxiang Han
Wayne W. Hancock
William A. Kuziel
P304
P3181
P356
10.4049/JIMMUNOL.171.12.6929
P407
P577
2003-12-15T00:00:00Z